At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...

TORONTO, July 24, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative ...

Prostate cancer is the most common cancer among men in the US, aside from skin cancer. About 13% of male Americans will get it — and treatment often comes with the risk of erectile dysfunction. Relief ...

Prostate cancer ranks as the most prevalent form of cancer among men, following only skin cancer in diagnosis frequency. Upon receiving a diagnosis, comprehending the available treatment options ...

NEW YORK (Reuters Health) - Robot surgery for prostate cancer lowered the rate of urinary complications compared with hands-on surgery in a new Italian study. While the study was small and contradicts ...

- Whole-gland TULSA ablation demonstrates statistically significant superior penile length preservation compared to robotic RP at 1 month - TORONTO, July 24, 2026 (GLOBE NEWSWIRE) -- Profound Medical ...